Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity.
By S. Kim, Ji Eun Park, Yoon-Jae Lee, H. Seo, S. Sheen, S. Hahn, B. Jang, H. Son. Journal of Clinical Epidemiology, 2013
1,056 citations recorded by the source corpus.
Subfields: Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/5b67133b75321bb96d2c1e9e203b81f420ac7f34
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Statistics and Probability
Citations in the corpus
- The Relationship Between Challenge and Threat States and Performance: A Systematic Review (2019, methodology): “Further, to assess the quality and risk of bias in experimental and non-experimental studies, respectively, the Cochrane Collaboration’s tool for assessing risk of bias (Higgins & Altman, 2008) and the Risk of Bias Assessment Tool for Nonrandomised Studies (Kim et al., 2013) were used.”
- Long-term risks and benefits associated with cesarean delivery for mother, baby, and subsequent pregnancies: Systematic review and meta-analysis (2018, methodology): “As an additional assessment of bias and study quality, we used the Risk of Bias Assessment tool for Non-randomized Studies (RoBANS), which has shown moderate reliability and promising validity [16].”
- Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. (2016, methodology): “The same reviewers independently evaluated the risk of bias of included RCTs with the Cochrane risk of bias tool(16) and assessed the quality of cohort studies with the Newcastle-Ottawa scale.(17) Disagreement was resolved by joint review of the”
- The Triple P-Positive Parenting Program: a systematic review and meta-analysis of a multi-level system of parenting support. (2014, methodology): “The Cochrane risk of bias tool (Higgins & Altman, 2008) was used to evaluate the randomized trials (RCTs and cluster randomized trials)and theRiskof BiasAssessment Tool for Nonrandomized Studies(RoBANS; Kim et al., 2013) wasusedto evaluate the non-randomized trials.”